Key facts
- This page summarizes Sharon E. Underberg's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Aug 2025, 17:00.
Sharon E. Underberg - 08 Aug 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Reporting relationship
- EVP, GC & Corporate Secretary
- Issuer ticker
- IDXX
- Reported as of
- 08 Aug 2025
- Net transaction value
- -$2,323,830
- SEC form
- 4
- Accepted by SEC
- 12 Aug 2025, 17:00:39 UTC
- Prior SEC filing
- 18 Feb 2025
- Next SEC filing
- 17 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sharon E. Underberg filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 12 Aug 2025.
Change
- Previous filing in this sequence was filed on 18 Feb 2025.
- Current net transaction value: -$2,323,830.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001630353
Primary reporting owner
Underberg Sharon E.
- Relationship
- EVP, GC & Corporate Secretary
- Address
- ONE IDEXX DRIVE, WESTBROOK
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Sharon E. Underberg
- Signature date
- 12 Aug 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $1,127,823
- Shares
- +5,450
- Change %
- +89%
- Price
- $206.94
- Shares after
- 11,606
- Date
- 08 Aug 2025
- Ownership
- Direct
- Footnotes
- F1
IDXX
transaction
Common Stock
Sale
- Transaction value
- $3,551,220
- Shares
- -5,450
- Change %
- -47%
- Price
- $651.60
- Shares after
- 6,156
- Date
- 08 Aug 2025
- Ownership
- Direct
IDXX
transaction
Common Stock
Options Exercise
- Transaction value
- $99,567
- Shares
- +183
- Change %
- +3%
- Price
- $544.08
- Shares after
- 6,339
- Date
- 12 Aug 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IDXX
transaction
Derivative
Non-Qualified Stock Option (right-to-buy)
Options Exercise
- Transaction value
- $0
- Shares
- -5,450
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 08 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,450
- Exercise price
- $206.94
- Footnotes
- F2
IDXX
transaction
Derivative
Incentive Stock Option (right-to-buy)
Options Exercise
- Transaction value
- $0
- Shares
- -183
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 12 Aug 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 183
- Exercise price
- $544.08
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Includes a total of 28.7090 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
Footnote F2
Grant of option to buy shares of Issuer common stock that became exercisable in four annual installments beginning on February 14, 2020.
Footnote F3
Grant of option to buy shares of Issuer common stock that became exercisable in one installment on February 14, 2025.